← FDA Drug Approvals (Drugs@FDA)

LORATADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2018-12-21

Drug application

FDA Application #
ANDA202538
Application type
Abbreviated New Drug Application (Generic)
Brand name
LORATADINE
Generic name
LORATADINE
Active ingredients
LORATADINE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Over-the-counter
Sponsor
BIONPHARMA
Manufacturer
Bionpharma Inc.
First approval
2018-12-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown